Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
An Unexpected Journey From Novice MSL to Global Medical Excellence Leader with Tonya Johnson
Summary
In this episode, Tom Caravela welcomes Dr. Tanya Johnson, who shares her inspiring journey from Newark to becoming a Medical Science Liaison (MSL). Tanya emphasizes the importance of networking and mentorship in the MSL field and offers insights into building and maintaining strong Key Opinion Leader (KOL) relationships. She discusses career development strategies, the roles of mentors and sponsors, and proactive career management. Tanya also explores the global medical excellence leader role and highlights key skills and emotional intelligence necessary for MSLs today. The episode concludes with Tanya's thoughts on future directions for MSLs.
My guest today is Dr. Tonya Johnson, she was a former Global Medical leader of MSL Excellence. We discuss TJ’s trek from no experience to Global Medical Affairs leader.
In this episode we discuss:
- Who is Tonya
- Transitioning to the industry
- The concept of mentors and sponsors
- The approach to finding a mentor or a sponsor
- Finding mentors
- What is Global Medical Excellence
- What skills are mandatory for the MSLs of today
Medical Science Liaison, networking and mentorship, Key Opinion Leader relationships, career development strategies, emotional intelligence for MSLs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary